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ABSTRACT
Cadmium (Cd
21) is a known carcinogen that inactiv-
ates the DNA mismatch repair (MMR) pathway. In this
study, we have tested the effect of Cd
21 exposure on
the enzymatic activity of the mismatch binding com-
plex MSH2–MSH6. Our results indicate that Cd
21 is
highly inhibitory to the ATP binding and hydrolysis
activities of MSH2–MSH6, and less inhibitory to its
DNA mismatch binding activity. The inhibition of
the ATPase activity appears to be dose and expo-
sure time dependent. However, the inhibition of the
ATPase activity by Cd
21 is prevented by cysteine
and histidine, suggesting that these residues are
essential for the ATPase activity and are targeted by
Cd
21. A comparison of the mechanism of inhibition
with N-ethyl maleimide, a sulfhydryl group inhibitor,
indicates that this inhibition does not occur through
direct inactivation of sulfhydryl groups. Zinc (Zn
21)
doesnotovercomethedirectinhibitoryeffectofCd
21
ontheMSH2–MSH6ATPaseactivityinvitro.However,
the increase in the mutator phenotype of yeast cells
exposedtoCd
21waspreventedbyexcessZn
21,prob-
ably by blocking the entry of Cd
21 into the cell. We
conclude that the inhibition of MMR by Cd
21 is
through the inactivation of the ATPase activity of
theMSH2–MSH6heterodimer,resultinginadominant
negative effect and causing a mutator phenotype.
INTRODUCTION
Mispaired bases result from incorporation errors during DNA
biosynthesis that have escaped the proofreading activity of
DNA polymerases as well as from the formation of hetero-
duplex DNA during recombination of divergent sequences.
DNA mismatch repair (MMR) plays a major role in the re-
cognition and correction of the mispaired bases, increasing
replication ﬁdelity and maintaining genome integrity. Defects
in MMR are the underlying cause of a cancer susceptibility
syndrome called HNPCC and account for 20% of sporadic
cancers (1).
MMR is a complex reaction that involves multiple proteins,
which recognize the mismatch, excise the DNA containing the
error and resynthesize the correct DNA sequence. In euka-
ryotes, six functional MMR genes have been identiﬁed,
MSH2, MSH3 and MSH6, which are homologs of MutS in
Escherichia coli, while MLH1, MLH3 and PMS2 (PMS1 in
yeast) are homologous to bacterial MutL (2–4). These genes
are involved in the recognition of the mismatch, a critical step
in the pathway, as illustrated by the fact that defects in these
genes account for two-thirds of HNPCC cases. The initial
recognition of mispairs is carried out by two protein com-
plexes: the MSH2–MSH6 heterodimer, also known as
MutSa, which recognizes base–base mismatches and frame-
shift mispairs (–1 bp), while the MSH2–MSH3 heterodimer,
also known as MutSb, recognizes frameshifts and larger in-
sertion deletion mispairs (2–4 bp). The MutL homologs
MLH1, PMS2 (PMS1 in yeast) and MLH3 form heterodimers
MLH1–PMS1 and MLH1–MLH3, which participate in down-
stream events subsequent to the recognition of mismatches by
the MSH complexes. Because of their requirement in the
repair of both types of mispairs, MSH2 and MLH1 are
regarded as the key factors in MMR as defects in the genes
encoding these proteins result in a complete loss of repair.
ATP binding and hydrolysis by the dimeric MSH protein
complexes is a critical aspect of MMR and is believed to
modulate the interactions of MSH2–MSH6 and MSH2–MSH3
with the mismatched DNA and other downstream factors
(5–7). Several models have been proposed regarding the
role of ATP in the recognition of mismatches by the MSH
protein complexes, most of which agree on the basic principle
of an ATP-dependent movement of the MSH heterodimers
along the mismatched DNA following mismatch recognition.
Thus, the presence of ATP reduces the steady-state afﬁnity of
MutSa for mismatched DNA (8). Opinions have differed
regarding the fate of the ATP molecule. Some authors have
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doi:10.1093/nar/gki291suggested that hydrolysis of the ATP molecule and the energy
generated thereby is necessary for the translocation of MSH
proteins (6,9), while others have suggested that ATP binding
alone can do the same (10,11). Formation of higher-order
structures of the MSH2–MSH6 dimer with proteins, such as
MLH1–PMS1 and PCNA, in the presence of ATP and mis-
matched DNA has also been reported previously (11–13).
Because of the essential role of ATP in MMR, it is likely
that defects in ATP binding and hydrolysis severely affect the
pathway. Mutations in the ATP-binding site of MSH2–MSH6
result in dominant negative alleles that exhibit a strong mut-
ator phenotype (14,15). Cadmium (Cd
2+) was shown recently
toimpairthisessential DNA repair pathwayinyeast, aswell as
in human cells in vivo (16).
Cd
2+ is a ubiquitous metal with no known biological func-
tion, to which humans are exposed mainly through occupation,
environmental contamination and from cigarette smoke (17).
The deleterious effects of Cd
2+ reported to date include gen-
eration of reactive oxygen species, inhibition of DNA repair,
depletion of glutathione, alteration of apoptosis and enhanced
peripheral arterial disease (18,19). Cd
2+ has also been reported
to have a high afﬁnity for protein sulfhydryl groups, can com-
pete with and replace Zn
2+ in proteins, and can bind to DNA at
random, causing single-strand DNA breaks (20,21).
In light of the reported inhibitory effect of Cd
2+ on the DNA
MMR machinery, we took a biochemical approach to further
deﬁne the role of Cd
2+ on MMR inhibition. Our results
described here demonstrate the direct effects of Cd
2+ on the
MSH2–MSH6 dimer. We observed inhibition of ATP binding,
concomitant with inhibition of the ATPase activity, as well as
inhibition of the mispaired DNA-binding activity of MSH2–
MSH6 in the presence of Cd
2+, with the inhibition of the
ATPase activity being signiﬁcantly more pronounced. This
inhibitory effect was also observed to be dose and exposure
time dependent. In addition, a comparison of the inhibitory
effect of Cd
2+ on the ATPase activity of MSH2–MSH6 with
N-ethyl maleimide (NEM), a sulfhydryl group inactivating
compound, indicated that their methods of inhibition are dif-
ferent. However, Cd
2+ was seen to bind to cysteine, a sulfur
containing amino acid. Zn
2+, a member of the same group in
the periodic table as Cd
2+, and a known antagonist of the
mutagenic effects of Cd
2+ (18,22), enhanced the inhibitory
effect of Cd
2+ in vitro. However, Zn
2+ reduced the appearance
of an increased mutator phenotype in yeast cells exposed to
Cd
2+. We propose a mechanism of inhibition whereby Cd
2+
allows MSH2–MSH6 to bind to a mispair but prevents ATP
hydrolysis, effectively abrogating the pathway at this stage.
MATERIALS AND METHODS
Purification of MSH2–MSH6
Saccharomyces cerevisiae MSH2–MSH6 was puriﬁed by
chromatography on PBE94, single-stranded DNA (ssDNA)
cellulose and Q Sepharose as described previously (23). Purity
was estimated to be at least 90% by Coomassie-stained gels.
ATPase assay
Themeasurementofhydrolysisof[g-
32P]ATPintoADPandPi
by the MSH2–MSH6 was carried out as described previously
(24). Brieﬂy, the reaction was carried out in Buffer A
containing 20 mM Tris–HCl, pH 7.5, 100 mM NaCl,
5% glycerol, 5.7 mgm l
 1 activated calf thymus DNA and
2m M[ g-
32P]ATP. MSH2–MSH6 was pre-incubated with
Cd
2+ at 4 C for 10 min, mixed with the reaction buffer and
incubated at 37 C for 30 min. Aliquots (1 ml) of each reaction
were spotted onto a polyethyleneamide-TLC plate (Sigma).
ATP and Pi were separated by chromatography in 1 M formic
acid and 0.5 M LiCl. Products were analyzed in a Phosphor-
Imager and quantitated using the ImageQuant software. One
unit of ATPase activity was deﬁned as the amount of protein
that hydrolyzed 1 pmol of ATP to ADP and Pi under the above
mentioned conditions.
To assay for the inhibition of MSH2–MSH6 ATPase activ-
ity by Cd
2+ in the presence of Zn
2+, MSH2–MSH6 (5 mg) was
pre-incubated with 50 mMC d
2+,5 0mMZ n
2+ and a combina-
tion of both in Buffer B (50 mM Tris–HCl, pH 7.5, 100 mM
NaCl and 0.5 mM EDTA) in a total volume of 100 ml for 10
min. To remove excess metal ions, the protein–metal mixtures
were dialyzed against 500 ml Buffer B for 3 h with one change
of buffer. The protein contents of the dialyzed mixtures were
recovered and quantiﬁed by Bradford (Bio-Rad). MSH2–
MSH6–Cd
2+ complex (40 nM) was pre-incubated with
50 mMZ n
2+. In addition, undialyzed MSH2–MSH6 protein
(40 nM) was pre-incubated with 50 mMZ n
2+,5 0mMC d
2+ and
a combination of both. The dialyzed and undialyzed metal-
treated samples were then incubated with Buffer A at 37 C
for 30 min and spotted on a TLC plate. Chromatography was
carried out as described above.
To test the effect of Cd
2+ on sulfhydryl groups, the inhibi-
tion of MSH2–MSH6 ATPase activity was compared with that
caused by NEM, a sulfhydryl alkylating agent. MSH2–MSH6
(5 mg) was pre-incubated with Cd
2+ (0.5 mM) in Buffer B at
4 C for 10 min as described above. To remove excess Cd
2+,
the protein was then dialyzed against 500 ml Buffer B for 3 h
with one change of buffer. The protein contents of the dialyzed
mixtures were measured. The dialyzed Cd
2+-treated MSH2–
MSH6 protein (40 nM) was then pre-incubated with 5 mM
NEM. In addition, 40 nM undialyzed MSH2–MSH6 protein
was pre-incubated with 0.5 mM Cd
2+, 5 mM NEM and a
combination of both at 4 C for 10 min. The reaction mixtures
were then incubated at 37 C for 30 min with the Buffer A,
spotted on a TLC plate and analyzed as described above.
To determine whether reducing agents containing sulfhy-
dryl groups could reverse the inhibitory effect of Cd2+ on the
ATPase activity, MSH2–MSH6 protein (160 nM) was pre-
incubated with excess of either Cd
2+ (0.5 mM) or NEM
(5 mM) at 4 C for 30 min, after which 2 mM DTT was
added and the mixture was further incubated for 30 min. In
addition, to test the capacity of DTT to prevent sulfhydryl
group inhibition, MSH2–MSH6 was pre-incubated ﬁrst with
2 mM DTT for 30 min, after which either Cd
2+ (0.5 mM) or
NEM (5 mM) was added and the mixture was incubated for an
additional 30 min. As a control, MSH2–MSH6 was pre-
incubated with either Cd
2+ (0.5 mM) or NEM (5 mM) for
30min. Thereaction mixtures were then incubatedwithBuffer
Aa t3 7  C for 30 min and spotted on a TLC plate and assayed
as described above.
The effect of different amino acids on Cd
2+-induced inhibi-
tion of MSH2–MSH6 was performed as follows. Stock
solution of amino acids (0.1 M) was made in water, and the
pH was the adjusted to 7.0. Cysteine is oxidized to cystine at
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Therefore, the pH of the cysteine solution was kept at pH 6.0.
Tryptophan was dissolved in dimethyl sulfoxide (DMSO) as
its solubility in water was very low. DMSO is inhibitory
toward the ATPase activity of MSH2–MSH6, so a control
reaction in the absence of Cd
2+ was carried out. Tyrosine
could not be dissolved in water, DMSO or ethanol and was
not tested. Cd2+ (0.5 mM) was pre-incubated with 10 mM
amino acid for 30 min at 4 C and then with MSH2–MSH6
(160 nM) at 4 C for 10 min. This mixture was then incubated
with Buffer A at 37 C for 30 min and spotted on TLC plates as
described above.
ATP binding to MSH2–MSH6
The ATP-binding assay was carried out with a Hoefer 25 mm
ﬁltration apparatus, pre-cooled to 4 C (25). Nitrocellulose
membranes (25 mm) (Whatman) were brieﬂy (30 s) soaked in
0.4 M KOH, extensively rinsed with distilled water and then
equilibrated with Buffer C (25 mM Tris–HCl, pH 7.6, 100 mM
NaCl and 10% v/v glycerol) at 4 C. MgCl2 was left out of the
buffer mixture to ensure ATP binding and not hydrolysis.
MSH2–MSH6 (100 nM) was pre-incubated with 0–0.5 mM
Cd
2+ at 4 C for 10 min in a total volume of 250 ml in Buffer C.
An aliquot (10 ml) of the mixture was taken out and incubated
with 2 mM [g
32P]ATP in Buffer A at 37 C for 30 min to assay
for ATP hydrolysis activity as described above. The remaining
mixture was further incubated with 1 mM[ a
32P]ATP for
10 min. Control reactions in the absence of Cd
2+ and
MSH2–MSH6 were also carried out. The binding mixture
was then applied to the equilibrated membranes, ﬁltered
under vacuum and washed extensively (20 ml) with Buffer
C. The ﬁlter membranes were dried at room temperature and
radioactivity was quantitated in a liquid scintillation counter.
Yeast mutator assays
The lys2-10A reversion assay was used to assay mutator
phenotype in yeast. Individual colonies of the strain
RDKY3590 (a gift from Dr R. Kolodner; Genotype: a,
ura3-52, leu2D1, trp1D63, hom3-10 and lys210A) was
grown in synthetic complete medium (3 ml) supplemented
with 2% glucose in presence of Cd
2+ (1 mM) or Zn
2+
(0–1 mM) or a combination of both. The cells were grown
to saturation overnight with shaking at 30 C, washed twice
with sterile water and resuspended in 1 ml sterile water.
Dilutions were plated on YPD to quantify survival and on
medium lacking lysine, to determine mutation frequency.
The appearance of revertant colonies was an indication of a
mutator phenotype. Mutation rates were determined by ﬂuc-
tuation analysis using at least ﬁve independent colonies per
experiment (26). Each ﬂuctuation test was repeated at least
three times.
Duplex DNA substrates
Substrates for MMR assays were prepared by annealing
200 pmol each of oligonucleotides (Invitrogen) 50-ATTTCCT-
TCAGCAGATAGGAACCATACTGATTCACAT-30 (HFRO
1107), 50-ATGTGAATCAGTATGGTTTCTATCTGCTGA-
AGGAAAT-30 (HFRO 1108) and 50-ATGTGAATCAGTGT-
TCCTATCTGCTGAAGGAAAT-30 (HFRO 1109). HFRO
1108 and HFRO 1109 were annealed to HFRO 1107, yielding
a G:T heteroduplex and a G:C homoduplex, respectively, by
heating at 95 C for 5 min in 100 ml annealing buffer (0.5 M
NaCl, 10 mM Tris–HCl, pH 7.5, 1 mM EDTA) and slow
cooling to 25 C over 3 h. To remove ssDNA, electrophoresis
of the DNA duplex was carried out in a 12% polyacrylamide
gel in TBE buffer (45 mM Tris-borate, 1 mM EDTA, pH 8.0)
at 150 V for 1 h under non-denaturing conditions. The band
containing the double-stranded DNA was excised from the gel
and DNA was extracted by phenol–chloroform extraction and
ethanol precipitation. The puriﬁed oligonucleotide (20 pmol)
was 50 end labeled with [g-
32P]ATP (Amersham) by incubat-
ing with T4 polynucleotide kinase (NEB) at37 Cfor30 min in
a reaction volume of 50 ml. Unincorporated [g-
32P]ATP was
removed by puriﬁcation in a G-25-Sephadex column (Roche).
To test for the removal of ssDNA, aliquots of the duplex DNA
were resolved in a 4.5% polyacrylamide gel under non-
denaturing conditions.
Gel mobility shift assay of DNA binding
The puriﬁed [g-
32P]ATP labeled duplex DNA (G:T and G:C)
was used as substrates for this assay. MSH2–MSH6 (80 nM)
was pre-incubated with 0–0.5 mM Cd
2+ at 4 C for 10 min and
then incubated with 100 fmol G:T or G:C substrate in a Buffer
D (20 mM HEPES-KOH, 5 mM MgCl2,5 0mgm l
 1 BSA and
50 mM NaCl) in a total volume of 20 mla t4  C for 15 min. The
reaction was stopped with 4ml of stop mixture (20% Ficoll and
0.75% bromophenol blue). Gel electrophoresis of 12 ml of the
mixture was carried out under non-denaturing conditions in a
4.5% polyacrylamide gel (60:1 bisacrylamide) containing 5%
glycerol in TBE buffer (45 mM Tris-borate, 1 mM EDTA, pH
8.0) at 10 V/cm at 4 C. Gels were dried and exposed on Kodak
BioMax ﬁlm. Analysis using a PhosphorImager and the
ImageQuant software was carried out.
Statistical analysis
Data analysis and graphingwas performed using the GraphPad
Prism 4 software package. Speciﬁc analysis for each experi-
ment is indicated in each Figure legend. In most cases, the
mean of at least three experiments is plotted together with the
standard deviation. Linear regression was used for best curve
ﬁtting when necessary and is indicated.
RESULTS
Effect of Cd
21 on the ATPase and DNA-binding
activities of MSH2–MSH6
Cd
2+ exposure resulted in a strong mutator phenotype in yeast
cells, as determined with frameshift mutation reporters (homo-
nucleotide runs in the LYS2 gene that revert by  1 frame-
shifts), indicating that it reduces the MMR capacity (16). The
initial mismatched DNA recognition and binding by the MSH
proteins are crucial steps of the MMR pathway. In addition,
ATP binding to the MSH proteins and hydrolysis are key
control points (27). Therefore, we hypothesized that at a bio-
chemical level, Cd
2+ may have an effect on these two very
important initial steps of the pathway.
The ATP hydrolytic activity of increasing amounts of puri-
ﬁed MSH2–MSH6 protein (0–160 nM) was tested in the pres-
ence of 100 mMC d
2+ (Figure 1a, gray bars) as described in
1412 Nucleic Acids Research, 2005, Vol. 33, No. 4Materials and Methods. A parallel reaction was carried out
where MSH2–MSH6 (0–160 nM) was pre-incubated with
Cd
2+ for 10 min, before assaying for ATPase activity
(Figure 1a, black bars). A control reaction of the ATP hydro-
lysis by MSH2–MSH6 (0–160 nM) in the absence of Cd
2+ was
also carried out (Figure 1a, white bars). The results indicate
that Cd
2+ severely inhibited the ATPase activity of MSH2–
MSH6atdifferentlevelsoftheprotein(Figure1a).Inaddition,
pre-incubation with Cd
2+ greatly enhanced the inhibitory
effect, e.g. at 60 nM of MSH2–MSH6, Cd
2+ pre-incubation
resulted in only 6% (2.3 pmol ATP hydrolyzed) of the activity
remaining, as opposed to 34% (13 pmol) of activity remaining
when no pre-incubation was performed.
To assay for the effect of increasing Cd
2+ concentration on a
ﬁxed amount of MSH2–MSH6, concentrations of 0–0.5 mM
Cd
2+ were pre-incubated with 80 and 160 nM MSH2–MSH6
and assayed for ATPase activity as described above. The res-
ults (Figure 1b) indicated that the Cd
2+-mediated inhibition of
MSH2–MSH6 is dose dependent. At lower concentrations
(Figure 1b, closed triangles), MSH2–MSH6 is signiﬁcantly
more sensitive to Cd
2+ inhibition with 50% inhibition obtained
with a Cd
2+ concentration of 87 mM versus 240 mM for the
higher concentration (Figure 1b, closed squares) of MSH2–
MSH6 tested. At higher concentrations of Cd
2+, the ATPase
activity was almost completely abolished. At the lower con-
centration of MSH2–MSH6 used (Figure 1b, closed triangles),
only 3% of the activity remained at 200 mMo fC d
2+, while 8%
activity remained at 500 mM for higher concentrations of
MSH2–MSH6 (Figure 1b, closed squares).
A time-course study of the inhibition of Cd
2+ (100 mM) with
MSH2–MSH6 (160 nM) conducted at various time points over
120 min pre-incubation indicated that the inhibition is time
dependent (Figure 1c). After 120 min pre-incubation with
Cd
2+ (Figure 1c, open triangles), MSH2–MSH6 displayed
only 30% of the activity observed with 1 min pre-incubation.
MSH2–MSH6 binds to DNA containing mismatches (23).
To determine the effect of Cd
2+ on the mismatched DNA-
binding activity, MSH2–MSH6 was pre-incubated with 0.1–
0.5 mM Cd
2+ and aliquots were taken and assayed for DNA
binding by gel mobility shift assay. DNA with mispairs (G:T)
or fully paired (G:C) were used as substrates. Cd2+ inhibited
the mismatched DNA-binding activity of MSH2–MSH6
(Figure 2a) in a dose-dependent manner. At the conditions
tested, the binding of MSH2–MSH6 to the G:C substrate
was negligible and was not signiﬁcantly affected by Cd
2+
treatment (data not shown). A comparison of the effect of
0–0.5 mM Cd
2+ on the ATPase and DNA-binding activity
of MSH2–MSH6 was carried out (Figure 2b). The data indic-
ate that while Cd
2+ causes a reduction in the mismatched
DNA-binding capacity of MSH2–MSH6 (Figure 2b, black
bars), it has a signiﬁcantly more pronounced inhibitory effect
on the ATPase activity of MSH2–MSH6 (Figure 2b, white
bars). At concentrations of Cd
2+ of 200 mM, 70% of the
DNA-binding activity of MSH2–MSH6 remained, compared
with only 8% of the ATPase activity, a 9-fold difference.
Similar effect was observed when higher concentrations of
Cd
2+ were used (Figure 2b). As a control, the DNA-binding
(a)
(b)
(c)
Figure 1. Effect of cadmium on the ATPase activity of MSH2–MSH6.
(a) Effect of 100 mMC d
2+ on increasing concentrations (0–160 nM) of
MSH2–MSH6. Pre-incubation of Cd
2+ with MSH2–MSH6 (black bars) at
4 C for 10 min followed by incubation with the reaction mixture containing
ATP at 37 C for 30 min. Direct incubation of MSH2–MSH6 (gray bars) with
Cd
2+ and ATP in reaction mixture at 37 C for 30 min without any pre-
incubation. ATPase activity of MSH2–MSH6 in the absence of Cd
2+ (white
bars). Each bar corresponds to the average of three experiments. Standard
deviation is indicated at the top of each bar. (b) Effect of increasing concentra-
tions of Cd
2+ (0–0.5 mM) on 160 nM (closed squares) and 80 nM (closed
triangles) of MSH2–MSH6. Pre-incubation of MSH2–MSH6 with Cd
2+ at
4 C for 10 min was carried out. The average of three experiments for each
concentrationofCd
2+ispresentedforMSH2–MSH6at160nMandtheaverage
offourexperimentsforMSH2–MSH6at80nM.Standarddeviationisincluded.
The curves were not fitted. (c) Time-course study over 120 min pre-incubation
of the ATPase activity of MSH2–MSH6 (160 nM) in the presence (closed
squares) and the absence of Cd
2+ (open triangles). The average of three experi-
ments for each time point is presented. Standard deviation is included. Curves
were fitted by linear regression analysis.
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was tested and found to not be inhibited by Cd
2+ (data not
shown).
Effect of Cd
21 on ATP-binding activity of
MSH2–MSH6
To assay the effect of Cd
2+ on the ATP-binding activity of
MSH2–MSH6, a nucleotide ﬁlter binding assay was carried
out. MSH2–MSH6 (100 nM) was incubated with 1 mM
[a
32P]ATP in the presence or absence of Cd
2+ and ﬁltered
throughnitrocellulosemembrane asdescribedinMaterialsand
Methods. ATP binding to MSH2–MSH6 resulted in retention
of radioactive signal on the membrane, which was measured
in a scintillation counter. To compare the ATP-binding activ-
ity (Figure 3, white bars) of MSH2–MSH6 with its ATP
hydrolysis activity (Figure 3, black bars) in the presence of
Cd
2+, an aliquot of the protein was simultaneously assayed for
hydrolysis activity. The data indicate that the MSH2–MSH6
ATP-binding activity was inhibited in the presence of Cd
2+
(Figure 3). The ATP-binding activity of MSH2–MSH6 was as
sensitive as the hydrolysis activity to Cd
2+ at every concen-
tration. These results are consistent with a mechanism of
inhibition of the MSH2–MSH6 ATPase activity as a con-
sequence of reduced ATP binding.
Effect of Zn
21 on the Cd
21-induced mutator
phenotype of yeast
Yeast cells show a strong mutator phenotype after exposure
to Cd
2+ (16). To test the effect of Zn
2+ on the Cd
2+-induced
mutator phenotype, the mutation rate in the presence of Cd
2+
(1 mM) and Zn
2+ (0–1000 mM) was determined using a yeast
strain carrying the lys2-10A allele as a reporter for mutation
accumulation. The results (Figure 4a and b) indicate that 1 mM
Cd
2+ is highly mutagenic to yeast, increasing the mutation rate
to 4.2 · 10
 6, a 221-fold effect compared with non-treated
cells (background rate is 1.9 · 10
 8). This inhibition is com-
parable with that observed in msh2 (9 · 10
 6) and mlh1
(1 · 10
 5) strains (data not shown). The presence of Zn
2+
causes a dose-dependent decrease in the mutator phenotype
of the lys2-10A cells. At a concentration of Zn
2+ of 1 mM,
equal to that of Cd
2+, the mutator phenotype was reduced to
43% (rate of 1.8 · 10
 6) to that observed with Cd
2+ alone. At
1000-fold higher Zn
2+ concentration than Cd
2+, the appear-
ance of a mutator phenotype was completely prevented yield-
ing a mutation rate of 3.9 · 10
 8, only 2-fold higher than
untreated cells (Figure 4b). Cell viability did not considerably
change at the concentration of Cd
2+ used. A determination of
the toxic concentrations of Cd
2+ resulted in survival of 100%
at 0 mM, 113% at 1 mM, 82% at 10 mM and 18% at 100 mM.
Figure 3.EffectofcadmiumontheATPhydrolysisandATP-bindingactivities
of MSH2–MSH6. MSH2–MSH6 was pre-incubated with Cd
2+ (0–0.5 mM) at
4 C for 10 min. Aliquots were withdrawn and assayed for ATP hydrolysis
(black bars) and ATP binding (white bars) as described in Materials and
Methods. Results are expressed as a percentage of the activity of MSH2–
MSH6 in the absence of Cd
2+. For ATP hydrolysis 100% corresponds to
200 pmol ATP hydrolyzed, while for ATP binding, 100% of the activity cor-
responds to 2 pmol ATP bound. The average of three experiments for each
concentration of Cd
2+ is presented. Standard deviation is included.
(a)
(b)
Figure 2. Effect of cadmium on the DNA-binding activity of MSH2–MSH6.
(a) MSH2–MSH6 was pre-incubated with Cd
2+ at 4 C for 10 min, mixed with
reaction mixture containinglabeled G/T mispairedDNA and further incubated
at 4 C for 15 min in 20 ml final volume. Gel was run with 10 ml of the mixture,
and autoradiographed. Quantitation was carried out with a phosphorImager.
(b) Comparison of the ATPase activity (white bars) and DNA mobility shift
activity (black bars) of MSH2–MSH6 (80 nM) in the presence of 0–0.5 mM
Cd
2+. Activity is presented as a percentage of the activity of MSH2–MSH6 in
the absence of Cd
2+ taken as 100%. The average of three experiments for each
concentration of Cd
2+ is presented. Bars also include standard deviation.
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ard deviation range was no more than 20% at each concen-
tration. This result reinforces the fact that at the concentration
of Cd
2+ used (1 mM), we are scoring for cadmium-induced
mutagenesis and not toxicity. Similarly, the concentrations of
Zn
2+ utilized in our experiments did not greatly reduce the
viability of the cells. Survival results of three independent
experiments were 100% at 0 mM, 97% at 0.1 mM, 78% at
1 mM and 6.4% at 10 mM Zn
2+. Because mutation rates were
determined by ﬂuctuation analysis using the method of Lea
and Coulson (26), the small reduction in viability observed
with Zn
2+ is intrinsic in the calculation. Combination of Zn
2+
and Cd
2+ resulted in survival similar to those obtained by Zn
2+
alone (data not shown). Thus, we conclude that Zn
2+ can
competitively reduce the Cd
2+-induced mutagenesis in vivo.
Role of Zn
21 in Cd
21 inhibition of MSH2–MSH6
activities
Cd
2+ and Zn
2+ belong to the same group on the periodic table.
Zn
2+ is an essential trace element that is required for several
cellular functions and has been shown to antagonize the
mutagenic effects of Cd
2+ (18). In the present study, we
determined the effect of Zn
2+ on the inhibition of the ATPase
activity of MSH2–MSH6 by Cd
2+. MSH2–MSH6 protein was
pre-incubated with either 50 mMC d
2+ or 50 mMZ n
2+ or a
combination of both as described in Materials and Methods.
The mixture was then dialyzed (denoted by D in Figure 4c) to
remove metal ions and tested for ATPase activity. The results
(Figure 4c) indicate that at the concentrations used, Zn
2+ and
Cd2+ resulted in the inhibition of the ATPase activity of
MSH2–MSH6 by  35% (Figure 4c, 2/6+Cd and 2/6+Zn).
However, when the metal ions were used in a combination,
the inhibitory effect was greatly enhanced resulting in  90%
inhibition (Figure 4c, 2/6+Cd+Zn). Dialysis resulted in recov-
ery of the activity to 80–90% of original activity for the single
metals [Figure 4c, (2/6+Cd)D and (2/6+Zn)D] and metal
combination [Figure 4c, (2/6+Cd+Zn)D], indicating that at
the concentrations of metal ions used, the inhibition was
reversible. In fact, the addition of Zn
2+ to dialyzed Cd
2+-
treated MSH2–MSH6 yielded an inhibition similar to that
obtained by Zn
2+ alone [Figure 4c, (2/6+Cd)D+Zn]. When
Cd
2+ was tested at a higher concentration (0.5 mM), a stronger
inhibitory effect was observed, which could only be partially
(a)
(b) (c)
Figure4.Effectofzinconthecadmium-inducedinhibitionofMMR.(a)Yeastmutatorassayusingastraincarryingthelys2-10Aallelewaspreformedinthepresence
of 1 mMC d
2+ and 0–1000mMZ n
2+. The appearance of Lys
+ revertant coloniesindicates a mutatorphenotype. (b) Effectof Zn
2+ on the mutatorrate ofthe lys2-10A
strain in the presence of Cd
2+. Each bar corresponds to the average of three sets of experiments using five independent colonies per set. Rates are calculated as
describedinMaterialsandMethodsandstandarddeviationisincludedatthetopofeachbar.(c)MSH2–MSH6(40nM)waspre-incubatedwith50mMCd
2+(2/6+Cd),
50 mMZ n
2+ (2/6+Zn) or a combination of both (2/6+Cd+Zn) at 4 C for 10 min and assayed for ATPase activity as described in Materials and Methods. To remove
excessmetalions,themixturewasdialyzed(denotedbyaDintheFigure)extensivelyandassayedforATPaseactivity.(2/6+Cd)DindicatesthatMSH2–MSH6was
treated with Cd
2+ followed by dialysis; (2/6+Zn)D indicates that MSH2–MSH6 was treated with Zn
2+ followed by dialysis; (2/6+Cd+Zn)D indicates that MSH2–
MSH6 was treated with Cd
2+ and Zn
2+ followed by dialysis; and (2/6+Cd)D+Zn indicates that MSH2–MSH6 was treated with Cd
2+ followed by dialysis, and then
treatedwithZn
2+.AcomparisonoftheATPaseactivityofthedialyzedandundialyzedMSH2–MSH6isshown.Theactivityofuntreated,undialyzedMSH2–MSH6
was used as 100% and corresponds to 26 pmol ATP hydrolyzed. Each set of experiments was repeated three times and the average is presented together with the
standard deviation.
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concentration of Cd
2+ results in a more severe and irreversible
inactivation of MSH2–MSH6.
Effect of sulfhydryl groups on Cd
21-induced inhibition
of MSH2–MSH6
Cd
2+ has been reported to have a high afﬁnity for sulfhydryl
groups (28) and has been proposed to speciﬁcally bind free
sulfhydryl groups in MMR proteins resulting in inhibition of
enzyme activities (20).
To determine whether Cd
2+ inhibits the ATPase activity of
MSH2–MSH6 by inactivating sulfhydryl groups, we com-
pared the inhibitory effects of Cd
2+ with that exerted by
NEM. As described in Materials and Methods, MSH2–
MSH6 was pre-incubated with 0.5 mM Cd
2+, 0.5 mM NEM
or both, and the ATPase activity was determined. As expected,
both agents (Figure 5a, 2/6+Cd and 2/6+NEM) signiﬁcantly
inhibited the ATPase activity of MSH2–MSH6 at the concen-
trations tested (Cd to 5% and NEM to 17% of original activ-
ity). When in combination (Figure 5a, 2/6+Cd+NEM), both
inhibitors resulted in an increased inactivation of the ATPase
activity (2% activity remaining), suggesting that Cd
2+ and
NEM most likely act at different sites of MSH2–MSH6.
When MSH2–MSH6 was pre-incubated with Cd
2+ or NEM,
followed by dialysis (denoted by D in Figure 5a) recovery
of the activity (from 5 to 14% of remaining activity)
was observed only for the Cd
2+-treated sample [Figure 5a,
(2/6+Cd)D], while the NEM treated sample [Figure 5a,
(2/6+NEM)D] did not signiﬁcantly change (from 17 to 19%
of activity), suggesting that inhibition by alkylation of sulf-
hydryl groups by NEM is stable. The dialyzed Cd
2+-treated
MSH2–MSH6 sample was still inhibited by NEM [Figure 5a,
(2/6+Cd)D+NEM], indicating that the target sites for NEM-
mediated inhibition are still available, and suggesting that
both Cd
2+ and NEM interact with different sites in
MSH2–MSH6.
To further investigate whether Cd
2+ inhibition was in part
due to binding to, or oxidation of free sulfhydryl groups, we
tested the effect of DTT, a sulfhydryl group-containing disulf-
ide bond reducing agent, on the inhibition of the ATPase
activity of MSH2–MSH6. For this purpose, the protein was
either
pre-incubated with DTT and then treated with either Cd
2+ or
NEM, or ﬁrst treated with Cd
2+ or NEM followed by the
addition of DTT. The ATPase activity was scored and com-
pared to that obtained in reactions where MSH2–MSH6 was
notincubatedwith DTT.When DTTwas added after treatment
of MSH2–MSH6 with Cd
2+, only a slight recovery of the
activity (from 4 to 12% of the activity remaining) was
observed (Figure 5b, 2/6+Cd and 2/6+Cd+DTT). Similarly,
when DTT was added to NEM treated MSH2–MSH6 (Figure
5b, 2/6+NEM and 2/6+NEM+DTT), only a slight recovery of
the activity was obtained (from 7 to 16% of the activity re-
maining). However, DTT was very efﬁcient at preventing the
(a)
(b)
Figure 5. Role of sulfhydryl groups as targets in the inhibition of the ATPase
activity of MSH2–MSH6 by cadmium. (a) Comparison of the inhibition of
ATPase activity by NEM and Cd
2+. MSH2–MSH6 (40 nM) was pre-incubated
with 0.5 mM Cd
2+ (2/6+Cd), 0.5 mM NEM (2/6+NEM) or a combination of
both (2/6+Cd+NEM) at 4 C for 10 min and assayed for ATPase activity. To
remove excess NEM and Cd
2+, the pre-incubation mixture was extensively
dialyzed (denoted as D in the Figure) and assayed for ATPase activity.
(2/6+Cd)D indicates that MSH2–MSH6 was treated with Cd
2+ followed by
dialysis; (2/6+NEM)D indicates that MSH2–MSH6 was treated with NEM
followed by dialysis; and (2/6+Cd)D+NEM indicates that MSH2–MSH6
was treated with Cd
2+ followed by dialysis, and the treated with NEM. The
comparison of the ATPase activities is shown here. The average of three
experiments is presented, bars include the standard deviation. (b) Effect of
DTT (2 mM) on the inhibition of the MSH2–MSH6 ATPase activity by Cd
2+
(0.5 mM) and NEM (5 mM). MSH2–MSH6 (160 nM) was pre-incubated with
Cd
2+ for 15 min (2/6+Cd), Cd
2+ for 15 min followed by DTT for 15 min
(2/6+Cd+DTT), DTT for 15 min followed by Cd
2+ for 15 min (2/6+DTT+Cd),
DTT+Cd),NEMfor15min(2/6+NEM),NEMfor15minfollowedbyDTTfor
15 min (2/6+NEM+DTT), and DTT for 15 min followed by NEM for 15 min
(2/6+DTT+NEM). The mixtures were then assayed for ATPase activity as
described in Materials and Methods. The average of three experiments is pre-
sented, including the standard deviation.
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reaction at the time of addition of the alkylating agent,
resulting in a recovery of 81% of the original ATPase activity
(Figure 5b, 2/6+DTT+NEM). Conversely, only a slight recov-
ery of activity (from 4 to 20%) was observed when the protein
was pre-incubated with DTT and then treated with Cd
2+
(Figure 5b, 2/6+DTT+Cd), suggesting that DTT does not
effectively bind to Cd
2+ as it does to NEM. These results
suggest that Cd
2+ inhibits the ATPase activity of MSH2–
MSH6 via a mechanism distinct from binding to or oxidation
of sulfhydryl groups.
Effect of amino acids on Cd
21 inhibition
To determine whether a speciﬁc amino acid residue is a target
of Cd
2+, we tested if amino acids could prevent the inhibition
the MSH2–MSH6 ATPase activity by Cd
2+. For this purpose,
Cd
2+ (0.5 mM) was pre-incubated with 10 mM of each of the
essential amino acids (except Tyr) for 30 min at 4 C before the
addition of MSH2–MSH6 (160 nM) at 4 C for 10 min. The
mixture was then assayed for ATPase activity as described
above. Of all the amino acids assayed, cysteine was the most
effective at preventing Cd
2+ inhibition of the ATPase, result-
ing in 88% of the activity remaining, versus 7% of remaining
activity when no amino acid was added (Table 1). Interest-
ingly, histidine was also effective in binding to Cd
2+ and
preventing the complete inactivation (33% activity remaining)
of the MSH2–MSH6 ATPase activity (Table 1). Other amino
acids had no or a marginal effect on preventing the inhibition
by Cd
2+.
DISCUSSION
Cd
2+ is a naturally occurring type I human carcinogen that is
used widely in the industry. Since Cd
2+ does not appear to
cause a direct mutagenic effect on DNA, it is likely that the
carcinogenicity of Cd
2+ is via aberrant gene activation, sup-
pressed apoptosis or altered DNA repair (18). Cd
2+ was shown
to inhibit the eukaryotic MMR pathway (16,22). It was also
shown to inhibit a number of other proteins involved in DNA
repair, such as apurinic/apyrimidinic (AP) endonuclease 1
(Ape1), bacterial formamidopyrimidine–DNA glycosylase
(Fpg protein), mammalian XPA protein, as well as the
H2O2 induced activation of poly(ADP–ribose)polymerase
(29–31). It has also been shown to deregulate the expression
of genes involved in controlling cell growth and division (32).
Metal ions, such as nickel, selenium and arsenic, have also
been proposedas DNA repair inhibitors (33–35). In the current
study, we have elucidated the biochemical nature of Cd
2+-
induced inhibition of MMR.
The primary ﬁndings of this study are (i) Cd
2+ inhibits the
ATP binding and hydrolysis activities of the MMR protein
MSH2–MSH6 and is less inhibitory toward the DNA-binding
activity of the protein. (ii) The inhibition is concentration and
exposure time dependent. (iii) Zn
2+ does not protect from the
inhibitory effect of Cd
2+ in vitro, rather, it exacerbates the
inhibition. However, in vivo, the presence of Zn
2+ reduces
the appearance of mutator phenotype induced by Cd
2+ in
yeast. (iv) The mechanism of inhibition is distinct from that
of NEM, a sulfhydryl group modiﬁer. (v) Cysteine, a sulfur
containing amino acid, and histidine are capable of binding to
Cd
2+ and preventing its inhibitory effect on the ATPase
activity of MSH2–MSH6.
The direct inhibition of eukaryotic MMR proteins by metal
ions has not been reported widely. We have shown in this
study that Cd
2+ strongly inhibits the ATPase activity of the
MSH2–MSH6 heterodimer. This could be a possible mech-
anism of inhibition of several of the transition metal ions that
have been designated as carcinogens. In addition, we have
shown that Cd2+ is less inhibitory toward the DNA-binding
activity of MSH2–MSH6, suggesting that ATP hydrolysis
defective protein may still recognize and bind to mispaired
DNA. A similar effect was seen with vanadate, an inhibitor of
bacterial MutS, which inhibited the DNA-binding activity by
 60%, while the ATPase activity was almost completely
abolished (36).
The antagonistic effect of Zn
2+ on Cd
2+ has been well docu-
mented, but has mostly focused on Cd
2+ toxicity (18). How-
ever, cells exposed to low Cd
2+ concentrations (1 mM) do not
present a detectable reduction in viability but display a signi-
ﬁcant increase in the mutator phenotype, indicating that at
these low levels, Cd
2+ is mutagenic. We demonstrate that
the mutagenic effect of Cd
2+ in vivo can be efﬁciently pre-
vented by Zn
2+. This is a very important observation, since
carcinogenesis by Cd
2+ is believed to occur through chronic
exposure to low levels of the metal. A recent report presents
similar results for human cells (22). A potential mechanism of
protection may involve a direct effect of Zn
2+ on MSH2–
MSH6 protein, since it has been suggested that Cd
2+ may
exert its carcinogenicity by replacing Zn
2+ from zinc ﬁnger
proteins as well as other binding domains that may be essential
for DNA repair (37). However, Zn
2+ failed to prevent the
Table 1. Effect of the essential amino acids on the inhibition of MSH2–MSH6
by cadmium
Amino acid added
a % ATPase activity (–SD)
 Cd
2+b +Cd
2+
None 100 7 (2.3)
Alanine 138 (8.3)
c 9 (1.6)
Arginine 94 (2.0) 5 (1.0)
Asparagine 120 (11.5) 4 (1.2)
Aspartic acid 121 (3.8) 10 (1.0)
Cysteine 122 (6.0) 88 (2.7)
Glutamine 125 (3.4) 6 (0.9)
Glutamic acid 133 (2.3) 14 (5.0)
Glycine 102 (5.0) 8 (1.0)
Histidine 113 (4.0) 33 (2.0)
Isoleucine 100 (1.0) 6 (0.7)
Leucine 102 (9.8) 8 (1.1)
Lysine 99 (7.0) 7 (0.5)
Methionine 110 (16.2) 9 (1.0)
Proline 105 (7.3) 7 (1.8)
Phenylalanine 104 (0.6) 8 (0.9)
Serine 107 (4.0) 8 (0.1)
Threonine 121 (0.4) 10 (0.5)
Tyrosine ND ND
Tryptophan 107 (10.7) 12 (2.5)
Valine 97 (1.6) 8 (0.5)
aAminoacids(10mM)werepre-incubatedwithCd
2+(0.5mM)for30minat4 C
and then with 160 nM MSH2–MSH6 at 4 C for 10 min. The mixture was then
incubatedwith2mM[g
32-P]ATPat37 Cfor30minandspottedonaTLCplate
as described in Materials and Methods.
bActivityexpressedaspercentageoftheATPaseactivityofMSH2–MSH6inthe
absenceof Cd
2+ and amino acids (100% activitycorrespondsto 200 pmolATP
hydrolyzed).
cNumbers in parenthesis represent standard deviation.
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2+on the MSH2–MSH6ATPaseactivity
in vitro. Furthermore, Zn
2+ enhanced the inhibitory effect of
Cd
2+ and was inhibitory on its own. No Zn
2+ ﬁnger has been
described in MSH2–MSH6 and this is consistent with the lack
of protection effect by Zn
2+ at the protein level. The mech-
anism by which Zn
2+ inhibits MSH2–MSH6 is not known at
this time. Other reports of the inhibitory effects of Zn
2+ have
been published. For example, the Mg2+ dependent (Na
+K
+)
ATPase activity, which is essential for cell excitability, was
shown to be competitively inhibited by Zn
2+ in electrocytes
from Electrophorus electricus (38), and the (Ca
2+) ATPase
activity of human erythrocyte plasma membrane was also
shown to be inhibited by Zn
2+ ions (39).
A potential mechanism that explains the reduction of the
Cd
2+-induced mutagenesis by Zn
2+ may involve common
transporters, whereby the presence of Zn
2+ ions prevents
the Cd
2+ ions from being transported into the cells. Zn
2+
homeostasis is carefully controlled by several mechanisms
(40). Zn
2+ uptake into the cell is carried out by two mem-
brane transporters, Zrt1 and Zrt2 (41), which have highafﬁnity
(Km = 10 nM) and low afﬁnity (Km = 100 nM) for Zn
2+,
respectively. The expression of these transporters is activated
by transcription factor Zap1 when Zn
2+ levels are low (40).
Conversely, exposing the cell to high levels of Zn
2+ (zinc
shock) results ina rapid loss of Zrt1 uptake activityand protein
(40). This inactivation occurs through zinc-induced endocyt-
osis of the protein and subsequent degradation in the vacuole
(40), allowing the cell to tolerate exposure to high levels of
Zn
2+. In yeast, Cd
2+ uptake has been shown to be mediated by
the zinc transporter Zrt1 (42,43).This observationisconsistent
with our ﬁndings. We believe that when cells are exposed to
high levels of Zn
2+ (zinc shock), the Zrt1 transporter is intern-
alized preventing, or signiﬁcantly reducing the entry of Cd
2+.
Under these conditions, the levels of intracellular Cd
2+ would
be too low to inactivate MMR and cause a mutator phenotype.
This is consistent with our ﬁnding that increasing concentra-
tions of Zn
2+ reduce the mutator phenotype. This mechanism
also explains why exposure of cells to excess Zn
2+ did not
result in a mutator phenotype in vivo, although Zn
2+ can
inactivate the MSH2–MSH6 ATPase activity in vitro. Intra-
cellular Zn
2+ is compartmentalized and its level is tightly
controlled (40) in such a way that it is unlikely that normally
Zn
2+ reaches concentrations that interfere with MMR. High
levels of Zn
2+ are not normally toxic to the cell. However, at
very high levels Zn
2+ is toxic and results in reduced viability,
indicating the inactivation of other essential pathways.
Cd
2+ has been reported to react with thiol groups, particu-
larly glutathione (44). In our studies, we have shown that Cd
2+
and NEM (a sulfhydryl group alkylating agent) have distinct
mechanisms of inhibition of the ATPase activity of MSH2–
MSH6 and that the inhibitory effect of NEM but not Cd
2+ can
be reduced by DTT. Cd
2+ seems to be a more effective inhib-
itor of the ATPase activity of MSH2–MSH6, since higher
concentrations of NEM were necessary to exert the same
effect. However, when individual amino acids were assayed
for their ability to bind Cd
2+, cysteine was seen to bind very
strongly. These data suggest that Cd
2+ may be recognizing
additional features in the amino acid residue cysteine, besides
its free sulfhydryl group.
Interestingly, histidine was also found to bind to Cd
2+. The
role of histidine residues in ATP hydrolysis catalysis has been
documented. In fact, a mutation of the His728 residue in Taq
MutS was shown to almost completely inhibit its ATPase
activity (45). Mutation of the equivalent conserved His in
hMSH6 (H1248D) was found in an HNPCC patient, while
the same in yMSH6 (H1096A) was found to increase the
mutation rates (46,47). The binding of Cd
2+ to an essential
Hisresidue atthe ATP binding/hydrolysissiteof yeastMSH2–
MSH6 could be a possible mechanism of inhibition of this
protein and, consequently, of the MMR pathway.
Cys and His are components of zinc ﬁnger proteins, and
binding of Cd
2+ to such proteins has been proposed as a mech-
anismofinhibitionforDNArepairproteinsXPAandFpg(30).
Although Zn
2+ ﬁnger proteins are known to bind to DNA, our
studies indicate that Cd
2+ does not inhibit the mismatched
DNA binding of MSH2–MSH6 as strongly as its ATPase
activity. A conserved Phe residue in E.coli MutS, human
MSH6 and yeast MSH6 has been shown to be essential for
DNAbinding(15,48,49).Phe,however,didnotbindtoCd
2+in
our studies. Thus, it is possible that a zinc ﬁnger motif is not
involved in DNA binding in the MSH proteins. In bacterial
MutS, the ATP-binding domains of both MutS subunits inter-
act with each other and with the DNA-binding regions of both
proteins (50,51). This leads to a close connection between
ATP/ADP binding and DNA binding that is transferred
throughout the protein and affects either activities. Based
on this fact, it is possible that Cd
2+ binding to Cys and His
residues of potential zinc ﬁnger domains in MSH2–MSH6
causes a mild defect in DNA binding that is transmitted to
the ATP-binding sites of the proteins effectively blocking its
ATP binding and hydrolysis activities.
In conclusion, we propose that in the presence of Cd
2+, the
MSH2–MSH6 protein binds to mispaired DNA. However, as
the ATP binding and hydrolysis activities of the protein are
abolished, the pathway stalls at this stage resulting in a dom-
inant negative effect and a mutator phenotype. It remains to be
determined whether other components of the MMR pathway
(e.g. MSH2–MSH3, MLH1–PMS1, EXO1, etc.) are similarly
inactivated by Cd
2+.
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